{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T17:59:24Z","timestamp":1772906364279,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd011272","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,7,13]],"date-time":"2016-07-13T00:00:00Z","timestamp":1468368000000}}],"reference-count":116,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011272.pub2","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T14:45:51Z","timestamp":1468507551000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Rapamycin and rapalogs for tuberous sclerosis complex"],"prefix":"10.1002","volume":"2017","author":[{"given":"Teguh H","family":"Sasongko","sequence":"first","affiliation":[{"name":"International Medical University; Human Biology Division, School of Medicine; No. 126, Jalan Jalil Perkasa 19, Bukit Jalil Kuala Lumpur Malaysia 57000"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur Farrah Dila","family":"Ismail","sequence":"additional","affiliation":[{"name":"Universiti Sains Malaysia; Human Genome Center, School of Medical Sciences; 16150 Kubang Kerian Kota Bharu Kelantan Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZAMH","family":"Zabidi-Hussin","sequence":"additional","affiliation":[{"name":"Universiti Sains Malaysia; Center for Neuroscience Services and Research; Kelantan Malaysia"},{"name":"Universiti Sains Malaysia; Department of Pediatrics, School of Medical Sciences; USM Health Campus Kubang Kerian Kelantan Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,7,13]]},"reference":[{"issue":"9869","key":"10.1002\/14651858.CD011272.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0002|cit2","unstructured":"NCT00790400 Efficacy and safety of RAD001 in patients aged 18 and over with Angiomyolipoma associated with either tuberous sclerosis complex (TSC) or sporadic lymphangioleiomyomatosis (LAM) (EXIST-2) https:\/\/www.clinicaltrials.gov\/ct2\/show\/study\/NCT00790400?term=NCT00790400&rank=1"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0003|cit3","doi-asserted-by":"crossref","unstructured":"Franz D Lam D Cauwel H Jozwiak S Effect of everolimus on subependymal nodules (SENs) and tubers in patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Results from the exist-1 trial [abstract] Proceedings of the 65th American Academy of Neurology Annual Meeting San Diego, CA United States Lippincott Williams and Wilkins 2013","DOI":"10.1212\/WNL.80.7_supplement.P01.049"},{"issue":"9861","key":"10.1002\/14651858.CD011272.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"issue":"13","key":"10.1002\/14651858.CD011272.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S1470-2045(14)70489-9","article-title":"Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study","volume":"15","author":"Franz","year":"2014","journal-title":"The Lancet. Oncology"},{"issue":"6","key":"10.1002\/14651858.CD011272.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/ndt\/gfu013","article-title":"The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1","volume":"29","author":"Kingswood","year":"2014","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0007|cit7","unstructured":"NCT00789828 Efficacy and safety of Everolimus (RAD001) in patients of all ages with subependymal giant cell astrocytoma associated with tuberous sclerosis complex (TSC)(EXIST-1) https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00789828?term=NCT00789828&rank=1"},{"issue":"3","key":"10.1002\/14651858.CD011272.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/11634580-000000000-00000","article-title":"Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin","volume":"12","author":"Koenig","year":"2012","journal-title":"Drugs in R&D"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0009|cit9","unstructured":"NCT01031901 Topical rapamycin therapy to alleviate cutaneous manifestations of tuberous sclerosis complex (TSC) and neurofibromatosis I (NF1) https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01031901?term=NCT01031901&rank=1"},{"issue":"4","key":"10.1002\/14651858.CD011272.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3171\/2010.7.PEDS10221","article-title":"Rapamycin as an alternative to surgical treatment of subependymal giant cell astrocytomas in a patient with tuberous sclerosis complex","volume":"6","author":"Birca","year":"2010","journal-title":"Journal of Neurosurgery. Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD011272.pub2-BIB0011|cit11","first-page":"292","article-title":"Effects of rapamycin on angiomyolipomas in patients with tuberous sclerosis","volume":"31","author":"Cabrera Lopez","year":"2011","journal-title":"Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia"},{"issue":"9","key":"10.1002\/14651858.CD011272.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"e23379","DOI":"10.1371\/journal.pone.0023379","article-title":"Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease","volume":"6","author":"Dabora","year":"2011","journal-title":"PloS one"},{"issue":"12","key":"10.1002\/14651858.CD011272.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","article-title":"Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial","volume":"17","author":"Davies","year":"2011","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"issue":"1","key":"10.1002\/14651858.CD011272.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1440-0960.2011.00837.x","article-title":"Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: a pilot study of four patients","volume":"53","author":"Foster","year":"2012","journal-title":"The Australasian Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD011272.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD011272.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejim.2006.07.017","article-title":"Dramatic effect of sirolimus on renal angiomyolipomas in a patient with tuberous sclerosis complex","volume":"18","author":"Herry","year":"2007","journal-title":"European Journal of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011272.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2133.2008.08677.x","article-title":"The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis","volume":"159","author":"Hofbauer","year":"2008","journal-title":"The British Journal of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD011272.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1177\/0883073808321764","article-title":"Regression of subependymal giant cell astrocytoma with rapamycin in tuberous sclerosis complex","volume":"23","author":"Koenig","year":"2008","journal-title":"Journal of Child Neurology"},{"issue":"19","key":"10.1002\/14651858.CD011272.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011272.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/pbc.22298","article-title":"Rapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous system tumors","volume":"54","author":"Lam","year":"2010","journal-title":"Pediatric Blood & Cancer"},{"issue":"7","key":"10.1002\/14651858.CD011272.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/pbc.22401","article-title":"Sirolimus therapy for fibromatosis and multifocal renal cell carcinoma in a child with tuberous sclerosis complex","volume":"54","author":"Pressey","year":"2010","journal-title":"Pediatric Blood & Cancer"},{"issue":"10","key":"10.1002\/14651858.CD011272.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1468-3083.2011.04212.x","article-title":"Sustained clinical effectiveness and favorable safety profile of topical sirolimus for tuberous sclerosis - associated facial angiofibroma","volume":"26","author":"Salido","year":"2012","journal-title":"Journal of the European Academy of Dermatology and Venereology : JEADV"},{"issue":"6","key":"10.1002\/14651858.CD011272.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.pediatrneurol.2010.01.016","article-title":"Optic nerve tumor in tuberous sclerosis complex is not responsive to sirolimus","volume":"42","author":"Sparagana","year":"2010","journal-title":"Pediatric Neurology"},{"issue":"6","key":"10.1002\/14651858.CD011272.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s11255-012-0292-z","article-title":"Nephron-sparing resection of angiomyolipoma after sirolimus pretreatment in patients with tuberous sclerosis","volume":"44","author":"Staehler","year":"2012","journal-title":"International Urology and Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD011272.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/bjd.12567","article-title":"First left-right comparative study of topical rapamycin vs. vehicle for facial angiofibromas in patients with tuberous sclerosis complex","volume":"169","author":"Tanaka","year":"2013","journal-title":"The British journal of dermatology"},{"issue":"4","key":"10.1002\/14651858.CD011272.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1365-2133.2011.10471.x","article-title":"A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity","volume":"165","author":"Wataya-Kaneda","year":"2011","journal-title":"The British Journal of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD011272.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jamadermatol.2014.4298","article-title":"Clinical and Histologic Analysis of the Efficacy of Topical Rapamycin Therapy Against Hypomelanotic Macules in Tuberous Sclerosis Complex","volume":"151","author":"Wataya-Kaneda","year":"2015","journal-title":"JAMA Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD011272.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1053\/j.ajkd.2006.05.018","article-title":"Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex","volume":"48","author":"Wienecke","year":"2006","journal-title":"American Journal of Kidney Diseases : the official journal of the National Kidney Foundation"},{"issue":"1","key":"10.1002\/14651858.CD011272.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00381-010-1222-y","article-title":"Regression of subependymal giant cell astrocytomas with RAD001 (Everolimus) in tuberous sclerosis complex","volume":"27","author":"Yalon","year":"2011","journal-title":"Child's Nervous System : ChNS : official journal of the International Society for Pediatric Neurosurgery"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0030|cit30","unstructured":"NCT01289912 Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01289912?term=NCT01289912&rank=1 (accessed 14 March 2016)"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0031|cit31","unstructured":"NCT01526356 Topical Rapamycin to Erase Angiofibromas in TSC (Treatment) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01526356?term=NCT01526356&rank=1 (accessed 14 March 2016)"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0032|cit32","unstructured":"NCT01713946 A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures (EXIST-3) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01713946?term=NCT01713946&rank=1 (accessed 14 March 2016)"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0033|cit33","unstructured":"NCT01730209 Efficacy of RAD001\/Everolimus in Autism and NeuroPsychological Deficits in Children With TuberousSclerosis Complex (RAPIT) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01730209?term=NCT01730209&rank=1 (accessed 14 March 2016)"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0034|cit34","unstructured":"NCT01954693 A Study of Everolimus in the Treatment of Neurocognitive Problems in Tuberous Sclerosis (TRON) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01954693?term=NCT01954693&rank=1 (accessed 14 March 2016)"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0035|cit35","unstructured":"NCT02635789 Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous SclerosisComplex (TSC) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02635789?term=NCT02635789&rank=1 (accessed 14 March 2016)"},{"issue":"7","key":"10.1002\/14651858.CD011272.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.crad.2011.02.009","article-title":"Radiological evidence of lymphangioleiomyomatosis in female and male patients with tuberous sclerosis complex","volume":"66","author":"Adriaensen","year":"2011","journal-title":"Clinical Radiology"},{"issue":"1-4","key":"10.1002\/14651858.CD011272.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12154-008-0003-5","article-title":"Rapamycin and mTOR kinase inhibitors","volume":"1","author":"Ballou","year":"2008","journal-title":"Journal of Chemical Biology"},{"issue":"4","key":"10.1002\/14651858.CD011272.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.devcel.2007.03.020","article-title":"The two TORCs and Akt","volume":"12","author":"Bhaskar","year":"2007","journal-title":"Developmental Cell"},{"issue":"2","key":"10.1002\/14651858.CD011272.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0040|cit40","doi-asserted-by":"crossref","DOI":"10.1002\/9783527630073.ch15","article-title":"Renal manifestations of tuberous sclerosis complex","volume-title":"Tuberous Sclerosis Complex: Genes, Clinical Features, and Therapeutics","author":"Bissler","year":"2010"},{"issue":"2","key":"10.1002\/14651858.CD011272.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ceb.2008.12.011","article-title":"PI3K and mTOR inhibitors: a new generation of targeted anticancer agents","volume":"21","author":"Brachmann","year":"2009","journal-title":"Current opinion in cell biology"},{"issue":"2","key":"10.1002\/14651858.CD011272.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00381-013-2185-6","article-title":"Rapamycin has a beneficial effect on controlling epilepsy in children with tuberous sclerosis complex: results of 7 children from a cohort of 86","volume":"30","author":"Canpolat","year":"2014","journal-title":"Child's Nervous System : ChNS : official journal of the International Society for Pediatric Neurosurgery"},{"issue":"5","key":"10.1002\/14651858.CD011272.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jpeds.2013.12.053","article-title":"Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex","volume":"164","author":"Cardamone","year":"2014","journal-title":"The Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD011272.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s004390000348","article-title":"Molecular genetic advances in tuberous sclerosis","volume":"107","author":"Cheadle","year":"2000","journal-title":"Human Genetics"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/9783527630073.ch9","article-title":"Pathogenesis of TSC in the brain","volume-title":"Tuberous Sclerosis Complex: Genes, Clinical Features, and Therapeutics","author":"Crino","year":"2010"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0046|cit46","unstructured":"National Cancer Institute Common terminology criteria for adverse events, (CTCAE), version 3.0."},{"issue":"2","key":"10.1002\/14651858.CD011272.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1378\/chest.12-2813","article-title":"Lymphangioleiomyomatosis screening in women with tuberous sclerosis","volume":"144","author":"Cudzilo","year":"2013","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD011272.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"Dabora","year":"2001","journal-title":"American Journal of Human Genetics"},{"issue":"2","key":"10.1002\/14651858.CD011272.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1056\/NEJMc072500","article-title":"Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis","volume":"358","author":"Davies","year":"2008","journal-title":"The New England Journal of Medicine"},{"issue":"19","key":"10.1002\/14651858.CD011272.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomised trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"7","key":"10.1002\/14651858.CD011272.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","author":"European Chromosome 16 Tuberous Sclerosis Consortium","year":"1993","journal-title":"Cell"},{"issue":"1","key":"10.1002\/14651858.CD011272.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1866-1955-6-10","article-title":"Self-injury and aggression in tuberous sclerosis complex: cross syndrome comparison and associated risk markers","volume":"6","author":"Eden","year":"2014","journal-title":"Journal of Neurodevelopmental Disorders"},{"issue":"2","key":"10.1002\/14651858.CD011272.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.molmed.2010.10.002","article-title":"Rapamycin for treating tuberous sclerosis and autism spectrum disorders","volume":"17","author":"Ehninger","year":"2011","journal-title":"Trends in Molecular Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011272.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials:methodological issues","volume":"30","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"8","key":"10.1002\/14651858.CD011272.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrd2062","article-title":"Current development of mTOR inhibitors as anticancer agents","volume":"5","author":"Faivre","year":"2006","journal-title":"Nature reviews. Drug discovery"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0056|cit56","unstructured":"Falotico R Are all sirolimus analogs alike? Conference presentation at Angioplasty Summit; TCT Asia Pacific; 2005 Apr 28; Seoul, Korea 2005"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/9783527630073.ch11","article-title":"Subependymal Giant Cell Astrocytoma","volume-title":"Tuberous Sclerosis Complex: Genes, Clinical Features, and Therapeutics","author":"Franz","year":"2010"},{"issue":"11","key":"10.1002\/14651858.CD011272.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1101\/gad.901101","article-title":"TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth","volume":"15","author":"Gao","year":"2001","journal-title":"Genes & Development"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.rmed.2010.03.017","article-title":"Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies","volume":"104 Suppl 1","author":"Glasgow","year":"2010","journal-title":"Respiratory Medicine"},{"issue":"34","key":"10.1002\/14651858.CD011272.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"30958","DOI":"10.1074\/jbc.M202678200","article-title":"Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)","volume":"277","author":"Goncharova","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"issue":"7","key":"10.1002\/14651858.CD011272.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archdermatol.2010.125","article-title":"Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis","volume":"146","author":"Haemel","year":"2010","journal-title":"Archives of dermatology"},{"issue":"7417","key":"10.1002\/14651858.CD011272.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0063|cit63","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"6","key":"10.1002\/14651858.CD011272.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"e001493","DOI":"10.1161\/JAHA.114.001493","article-title":"Cardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the International Tuberous Sclerosis Consensus Group","volume":"3","author":"Hinton","year":"2014","journal-title":"Journal of the American Heart Association"},{"issue":"3","key":"10.1002\/14651858.CD011272.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/humu.22007","article-title":"Functional assessment of TSC1 missense variants identified in individuals with tuberous sclerosis complex","volume":"33","author":"Hoogeveen-Westerveld","year":"2012","journal-title":"Human Mutation"},{"issue":"1","key":"10.1002\/14651858.CD011272.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/humu.22202","article-title":"Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex","volume":"34","author":"Hoogeveen-Westerveld","year":"2013","journal-title":"Human Mutation"},{"issue":"5","key":"10.1002\/14651858.CD011272.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1001\/archneur.57.5.662","article-title":"National Institutes of Health consensus conference: tuberous sclerosis complex","volume":"57","author":"Hyman","year":"2000","journal-title":"Archives of neurology"},{"issue":"9","key":"10.1002\/14651858.CD011272.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nature Cell Biology"},{"issue":"1","key":"10.1002\/14651858.CD011272.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1183\/09031936.00076209","article-title":"European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis","volume":"35","author":"Johnson","year":"2010","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1002\/14651858.CD011272.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1017\/S0033291702007092","article-title":"Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex","volume":"33","author":"Joinson","year":"2003","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1007\/s002800051097","article-title":"Matrix metalloproteinases and metastasis","volume":"43 Suppl","author":"Kleiner","year":"1999","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0072|cit72","first-page":"21","article-title":"Renal tumors in postmortem material","volume":"59","author":"Kozlowska","year":"2008","journal-title":"Polish Journal of Pathology"},{"issue":"5","key":"10.1002\/14651858.CD011272.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.23960","article-title":"Everolimus treatment of refractory epilepsy in tuberous sclerosis complex","volume":"74","author":"Krueger","year":"2013","journal-title":"Annals of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD011272.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/hmg\/11.5.525","article-title":"A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells","volume":"11","author":"Kwiatkowski","year":"2002","journal-title":"Human Molecular Genetics"},{"issue":"Pt 1","key":"10.1002\/14651858.CD011272.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1469-1809.2003.00012.x","article-title":"Tuberous sclerosis: from tubers to mTOR","volume":"67","author":"Kwiatkowski","year":"2003","journal-title":"Annals of Human Genetics"},{"issue":"3","key":"10.1002\/14651858.CD011272.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/gcc.20118","article-title":"Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models","volume":"42","author":"Lee","year":"2005","journal-title":"Genes, Chromosomes & Cancer"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2210-9-8","article-title":"Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models","volume":"9","author":"Lee","year":"2009","journal-title":"BMC Pharmacology"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0078|cit78","unstructured":"Lefebvre C Manheimer E Glanville J on behalf of the Cochrane Information Retrieval Methods Group Chapter 6: Searching for studies. In Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 [Updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0079|cit79","unstructured":"Povey S Ekong R Tuberous sclerosis database: Tuberous sclerosis 1 (TSC1) http:\/\/chromium.liacs.nl\/LOVD2\/TSC\/home.php?select_db=TSC1"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0080|cit80","unstructured":"Povey S Ekong R Tuberous sclerosis database : Tuberous sclerosis 2 (TSC2) http:\/\/chromium.liacs.nl\/LOVD2\/TSC\/home.php?select_db=TSC2"},{"issue":"1","key":"10.1002\/14651858.CD011272.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/2229-5178.105488","article-title":"Topical rapamycin (sirolimus) for facial angiofibromas","volume":"4","author":"Madke","year":"2013","journal-title":"Indian dermatology online journal"},{"issue":"1","key":"10.1002\/14651858.CD011272.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","article-title":"Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway","volume":"10","author":"Manning","year":"2002","journal-title":"Molecular Cell"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0083|cit83","doi-asserted-by":"crossref","DOI":"10.1002\/9783527630073.ch17","article-title":"Lymphangioleiomyomatosis and pulmonary disease in TSC","volume-title":"Tuberous Sclerosis Complex: Genes, Clinical Features, and Therapeutics","author":"McCormack","year":"2010"},{"issue":"4","key":"10.1002\/14651858.CD011272.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/0883073808324535","article-title":"Rapamycin reduces seizure frequency in tuberous sclerosis complex","volume":"24","author":"Muncy","year":"2009","journal-title":"Journal of Child Neurology"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0085|cit85","doi-asserted-by":"crossref","unstructured":"Mutizwa MM Berk DR Anadkat MJ Treatment of facial angiofibromas with topical application of oral rapamycin solution (1mgmL(-1) ) in two patients with tuberous sclerosis The British Journal of Dermatology 2011 922 3","DOI":"10.1111\/j.1365-2133.2011.10476.x"},{"issue":"5","key":"10.1002\/14651858.CD011272.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/RCT.0b013e318264e404","article-title":"Multifocal micronodular pneumocyte hyperplasia: computed tomographic appearance and follow-up in tuberous sclerosis complex","volume":"36","author":"Muzykewicz","year":"2012","journal-title":"Journal of Computer Assisted Tomography"},{"issue":"7","key":"10.1002\/14651858.CD011272.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/138920208786241243","article-title":"Genetics and molecular biology of tuberous sclerosis complex","volume":"9","author":"Napolioni","year":"2008","journal-title":"Current Genomics"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0088|cit88","unstructured":"National Institute of Neurological Disorders and Stroke (NINDS) Tuberous sclerosis fact sheet www.ninds.nih.gov\/disorders\/tuberous_sclerosis\/detail_tuberous_sclerosis.htm"},{"issue":"4","key":"10.1002\/14651858.CD011272.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatric Neurology"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0090|cit90","unstructured":"Online Mendelian Inheritance in Man\u00ae - National Center for Biotechnology Information TUBEROUS SCLEROSIS 1; TSC1"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0091|cit91","unstructured":"Online Mendelian Inheritance in Man\u00ae - National Center for Biotechnology Information TUBEROUS SCLEROSIS 2; TSC2"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","article-title":"Epidemiology of tuberous sclerosis","volume":"615","author":"Osborne","year":"1991","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0093|cit93","doi-asserted-by":"crossref","unstructured":"Overwater IE Rietman AB Elgersma Y de Wit MC Treatment of intractable epilepsy in tuberous sclerosis complex with everolimus is not yet evidence-based Annals of Neurology 2014 163 4","DOI":"10.1002\/ana.24047"},{"issue":"9","key":"10.1002\/14651858.CD011272.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ncb840","article-title":"Akt regulates growth by directly phosphorylating Tsc2","volume":"4","author":"Potter","year":"2002","journal-title":"Nature Cell Biology"},{"issue":"12","key":"10.1002\/14651858.CD011272.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/088307389801301206","article-title":"Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria","volume":"13","author":"Roach","year":"1998","journal-title":"Journal of Child Neurology"},{"issue":"6","key":"10.1002\/14651858.CD011272.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/088307389901400610","article-title":"Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association","volume":"14","author":"Roach","year":"1999","journal-title":"Journal of child neurology"},{"issue":"2","key":"10.1002\/14651858.CD011272.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00726-004-0119-z","article-title":"Proteins interacting with the tuberous sclerosis gene products","volume":"27","author":"Rosner","year":"2004","journal-title":"Amino Acids"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0098|cit98","unstructured":"RxList: The Internet Drug Index Rapamune (Sirolimus) www.rxlist.com\/rapamune-drug.htm"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0099|cit99","unstructured":"RxList: The Internet Drug Index Torisel (Temsirolimus) http:\/\/www.rxlist.com\/torisel-drug.htm"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0100|cit100","unstructured":"RxList: The Internet Drug Index Afinitor (Everolimus) http:\/\/www.rxlist.com\/afinitor-drug.htm"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0101|cit101","doi-asserted-by":"crossref","unstructured":"Sasongko TH Ismail NFD Nik Mohd Ariff NAM Zabidi-Hussin ZAMH Rapamycin and its analogues (rapalogs) for tuberous sclerosis complex-associated tumors: a systematic review on non-randomized studies using meta-analysis http:\/\/www.ojrd.com\/content\/10\/1\/95","DOI":"10.1186\/s13023-015-0317-7"},{"issue":"5","key":"10.1002\/14651858.CD011272.pub2-BIB0102|cit102","first-page":"753","article-title":"Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat","volume":"20","author":"Sattler","year":"1992","journal-title":"Drug Metabolism & Disposition"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2261-14-66","article-title":"Rhabdomyomas and tuberous sclerosis complex: our experience in 33 cases","volume":"14","author":"Sciacca","year":"2014","journal-title":"BMC cardiovascular disorders"},{"issue":"12","key":"10.1002\/14651858.CD011272.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"806-13, W-294","DOI":"10.7326\/0003-4819-154-12-201106210-00008","article-title":"Recognition of tuberous sclerosis in adult women: delayed presentation with life-threatening consequences","volume":"154","author":"Seibert","year":"2011","journal-title":"Annals of Internal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD011272.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","article-title":"Causes of death in patients with tuberous sclerosis","volume":"66","author":"Shepherd","year":"1991","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0106|cit106","unstructured":"Tanzi MG Juice interactions: What patients need to know http:\/\/www.pharmacist.com\/juice-interactions-what-patients-need-know"},{"issue":"15","key":"10.1002\/14651858.CD011272.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","article-title":"Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb","volume":"13","author":"Tee","year":"2003","journal-title":"Current Biology"},{"issue":"5","key":"10.1002\/14651858.CD011272.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"e1335","DOI":"10.1542\/peds.2010-2910","article-title":"Regression of a cardiac rhabdomyoma in a patient receiving everolimus","volume":"127","author":"Tiberio","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD011272.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5070\/D36TB7N61M","article-title":"Facial angiofibromas treated with topical rapamycin: an excellent choice with fast response","volume":"18","author":"Truchuelo","year":"2012","journal-title":"Dermatology Online Journal"},{"issue":"11","key":"10.1002\/14651858.CD011272.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"e1005637","DOI":"10.1371\/journal.pgen.1005637","article-title":"Mosaic and Intronic Mutations in TSC1\/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing","volume":"11","author":"Tyburczy","year":"2015","journal-title":"PLoS Genetics"},{"issue":"5327","key":"10.1002\/14651858.CD011272.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"Slegtenhorst","year":"1997","journal-title":"Science (New York, N.Y.)"},{"issue":"4","key":"10.1002\/14651858.CD011272.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/jmg.36.4.285","article-title":"Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: no evidence for genotype-phenotype correlation","volume":"36","author":"Slegtenhorst","year":"1999","journal-title":"Journal of Medical Genetics"},{"issue":"1","key":"10.1002\/14651858.CD011272.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/archderm.148.1.138","article-title":"A novel application of topical rapamycin formulation, an inhibitor of mTOR, for patients with hypomelanotic macules in tuberous sclerosis complex","volume":"148","author":"Wataya-Kaneda","year":"2012","journal-title":"Archives of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD011272.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1177\/0883073813488664","article-title":"A novel topical rapamycin cream for the treatment of facial angiofibromas in tuberous sclerosis complex","volume":"28","author":"Wheless","year":"2013","journal-title":"Journal of Child Neurology"},{"issue":"2","key":"10.1002\/14651858.CD011272.pub2-BIB0115|cit115","first-page":"129","article-title":"Everolimus for the treatment of subependymal giant cell astrocytoma probably causing seizure aggravation in a child with tuberous sclerosis complex: a case report","volume":"45","author":"Wiemer-Kruel","year":"2014","journal-title":"Neuropediatrics"},{"key":"10.1002\/14651858.CD011272.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1756-8722-2-45","article-title":"Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy","volume":"2","author":"Yuan","year":"2009","journal-title":"Journal of Hematology & Oncology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd011272.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011272.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T01:08:07Z","timestamp":1748999287000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011272.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,7,13]]},"references-count":116,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011272.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD011272.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,13]]}}}